Selby_Lancet_CGH_January.pdf (213.79 kB)

The Lancet Gastroenterology & Hepatology Journal Cover January 2nd 2017

figure

posted on 2017-12-07, 14:14 authored by Andrew SelbyAndrew Selby

The strongest risk factor for oesophageal adenocarcinoma (OAC) is reflux disease, and the rising incidence coincides with the eradication of Helicobacter pylori, both of which may alter the oesophageal microbiota. We aimed to profile the microbiota at different stages of Barrett’s carcinogenesis and investigate the Cytosponge™ as a minimally invasive tool for sampling the oesophageal microbiota.

Funding

Dr Robert Brierley, Dr Heather Van Epps

History

School

The Arts, English and Drama

Department

Arts

Citation

SELBY, A., 2017. The Lancet Gastroenterology & Hepatology Journal Cover January 2nd 2017. The Lancet Gastroenterology & Hepatology Journal, 2(1)

Publisher

Elsevier

Version

VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Publication date

2017

Notes

This paper was published in the journal The Lancet Gastroenterology & Hepatology Journal and is available at http://www.thelancet.com/journals/langas/issue/vol2no1/PIIS2468-1253(16)X0006-4.